Cohance Lifesciences P/E Ratio

Current P/E Ratio
97.96
High Valuation
Very High - High growth expectations or significantly overvalued

Cohance Lifesciences P/E ratio. Cohance Lifesciences (COHANCE) P/E ratio is 97.96 (High), EPS (TTM) ₹4.69, current price ₹459.45 on NSE vs historical average P/E of 54.6 (83.3th percentile) — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see COHANCE stock price BSE.

Current Valuation Metrics

P/E Ratio 97.96
Current Price ₹459.45
EPS (TTM) ₹4.69
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 54.6
Historical Range 20.06 - 152.93
Percentile 83.3%

Sector Context

Sector Average 52.19
Sector Median 29.6
Sector Rank #11 of 256
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹2.22
Sept 2026 ₹0.40
Mar 2026 ₹0.51

COHANCE P/E Ratio — Valuation Signal & Historical Context

Cohance Lifesciences P/E 97.96 vs historical average 54.6, range 20.06–152.93 — signal: Overvalued. Also explore Cohance Lifesciences stock price data download to track price trends across different timeframes.

  • Stock appears overvalued with PE of 97.96, suggesting caution for new investments
  • Current PE is 79.4% above historical average
  • Trading at premium to sector average PE of 52.19

Cohance Lifesciences P/E Ratio Historical Trend

COHANCE annual price-to-earnings ratio — 6 years, EPS and year-end price. Current P/E 97.96 vs historical average 54.6. Check COHANCE company valuation to track the company's total market size over time.

COHANCE Historical P/E Ratio — EPS, Year-End Price & Valuation

Cohance Lifesciences annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 152.93 7.34 ₹1122.50 NSE High
2024 61.41 11.73 ₹720.35 NSE High
2023 33.66 14.58 ₹490.75 NSE High
2022 33.09 14.88 ₹492.35 NSE High
2021 26.45 17.5 ₹462.85 NSE High
2020 20.06 16.8 ₹337.05 NSE Moderate

COHANCE vs Healthcare Peers — P/E Ratio Comparison

Cohance Lifesciences P/E 97.96 vs Healthcare average 52.19, median 29.6 — range 2.0–733.0.

Sector Average
52.19
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
256
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low